Form 4: Annovis Bio Director Buys 15,000 Shares

Annovis Bio, Inc. Director Michael B. Hoffman acquired 15,000 shares of common stock at $2.11 per share.

Summary

• Director Michael B. Hoffman purchased 15,000 shares of Annovis Bio, Inc. common stock.
• The transaction occurred on November 14, 2025.
• The purchase price was $2.11 per share.
• Following this transaction, Hoffman directly owns 2,470,539 shares and indirectly owns 223,357 shares through The 2018 Jane and Michael Hoffman Descendants Trust.

Sentiment

Score: 7

Explanation: A director's purchase of company stock generally indicates confidence in the company's future, which is a positive signal for investors.

Positives

• A director's purchase of company stock can signal confidence in the company's future prospects.
• The purchase was made at a specific price of $2.11 per share, indicating a valuation point.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal of confidence in the company's valuation and future, potentially influencing stock price.

Key Dates

Recommendation

The purchase of 15,000 shares by a director at $2.11 per share is a positive signal, indicating management's confidence in the company's valuation and future prospects. However, without additional financial or strategic updates, this single transaction is insufficient to warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and monitor for further developments.

Keywords

Annovis Bio, ANVS, Insider Trading, Stock Purchase, Director, Michael B. Hoffman, SEC Form 4